Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA.
Verena KönigerLea HolstenUte HarrisonBenjamin BuschEva LoellQing ZhaoDaniel A BonsorAlexandra RothArnaud Kengmo-TchoupaStella I SmithSusanna MuellerEric J SundbergWolfgang ZimmermannWolfgang FischerChristof R HauckRainer HaasPublished in: Nature microbiology (2016)
Helicobacter pylori (Hp) strains that carry the cag type IV secretion system (cag-T4SS) to inject the cytotoxin-associated antigen A (CagA) into host cells are associated with peptic ulcer disease and gastric adenocarcinoma. CagA translocation by Hp is mediated by β1 integrin interaction of the cag-T4SS. However, other cellular receptors or bacterial outer membrane adhesins essential for this process are unknown. Here, we identify the HopQ protein as a genuine Hp adhesin, exploiting defined members of the carcinoembryonic antigen-related cell adhesion molecule family (CEACAMs) as host cell receptors. HopQ binds the amino-terminal IgV-like domain of human CEACAM1, CEACAM3, CEACAM5 or CEACAM6 proteins, thereby enabling translocation of the major pathogenicity factor CagA into host cells. The HopQ-CEACAM interaction is characterized by a remarkably high affinity (KD from 23 to 268 nM), which is independent of CEACAM glycosylation, identifying CEACAMs as bona fide protein receptors for Hp. Our data suggest that the HopQ-CEACAM interaction contributes to gastric colonization or Hp-induced pathologies, although the precise role and functional consequences of this interaction in vivo remain to be determined.
Keyphrases
- helicobacter pylori
- helicobacter pylori infection
- induced apoptosis
- endothelial cells
- cell adhesion
- cell cycle arrest
- induced pluripotent stem cells
- high glucose
- escherichia coli
- single cell
- pluripotent stem cells
- electronic health record
- photodynamic therapy
- stem cells
- oxidative stress
- metabolic syndrome
- type diabetes
- radiation therapy
- binding protein
- skeletal muscle
- cystic fibrosis
- insulin resistance